Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers

It may be possible to classify patients with Aβ positive (+) mild cognitive impairment (MCI) into fast and slow decliners according to their biomarker status. In this study, we aimed to develop a risk prediction model to predict fast decline in the Aβ+ MCI population using multimodal biomarkers. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Hyemin, Park, Jongyun, Woo, Sookyoung, Kim, Seonwoo, Kim, Hee Jin, Na, Duk L., Lockhart, Samuel N., Kim, Yeshin, Kim, Ko Woon, Cho, Soo Hyun, Kim, Seung Joo, Seong, Joon-Kyung, Seo, Sang Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677900/
https://www.ncbi.nlm.nih.gov/pubmed/31376643
http://dx.doi.org/10.1016/j.nicl.2019.101941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677900/
https://www.ncbi.nlm.nih.gov/pubmed/31376643
http://dx.doi.org/10.1016/j.nicl.2019.101941

Ejemplares similares